Supriya Lifescience closes trading window until Q1FY27 results
Supriya Lifescience Ltd. has closed its trading window for insiders and designated persons from July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending June 30, 2026, in compliance with SEBI regulations. The board meeting date for Q1FY27 results will be announced later.

*this image is generated using AI for illustrative purposes only.
Supriya Lifescience Ltd. has closed its trading window for all insiders and designated persons effective July 1, 2026, to prevent potential insider trading ahead of its quarterly financial announcement. The restriction will remain in force until 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2026. This measure is in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the company's internal code of conduct.
The closure applies to securities of supriya lifescience and covers insiders, designated persons, and their immediate relatives as defined in the code. The company stated that the specific date for the board meeting to consider and declare the unaudited financial results for Q1FY27 will be communicated in due course.
Trading Window Schedule
| Event | Date |
|---|---|
| Trading window closure | July 01, 2026 |
| Quarter end | June 30, 2026 |
| Trading window reopens | 48 hours after results declaration |
Historical Stock Returns for Supriya Lifescience
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.01% | -0.51% | +36.29% | +27.61% | +38.96% | +138.51% |
What market performance does Supriya Lifescience anticipate for Q1FY27 given the early implementation of trading restrictions?
How might the extended trading window closure impact liquidity and stock volatility ahead of the earnings announcement?
Will the company provide any guidance or strategic updates alongside the unaudited financial results for the quarter?

































